Brief: Mustang Bio Reports Full-Year 2020 Financial Results And Recent Corporate Highlights
March 24 (Reuters) - Mustang Bio Inc MBIO.O :
* MUSTANG BIO REPORTS FULL-YEAR 2020 FINANCIAL RESULTS AND
RECENT
CORPORATE HIGHLIGHTS
* MUSTANG BIO INC - AS OF DEC 31, 2020, CO'S CASH AND CASH
EQUIVALENTS AND RESTRICTED CASH TOTALED $98.8 MILLION
* MUSTANG BIO INC - EXPECTS TO FILE AN IND IN Q2 OF 2021 FOR
ITS
PIVOTAL MULTICENTER PHASE 2 CLINICAL TRIAL OF MB-207
Source text for Eikon: ID:nGNX6mgGFL
Further company coverage: MBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie